Facts and Figures
[THIS IS DEMO CONTENT]
MEDIVABLE was founded in 2020 with the goal of revolutionizing the healthcare industry through its innovative digital health solutions. The company's flagship product is a remote monitoring platform that allows physicians to closely monitor patients with chronic conditions in real-time.
- In its first year, MEDIVABLE has partnered with several leading hospitals and healthcare providers in France to implement its remote monitoring platform.
- The company has also attracted significant private investment from notable investors in the healthcare industry.
- MEDIVABLE is currently conducting clinical trials to demonstrate the effectiveness of its solution and plans to seek certification as a Class 1 medical device in the near future.
Financing Phases:
- Seed funding round in Q4 2021
- Series A funding round planned for Q2 2022
Awards & Certifications:
- None to date, but MEDIVABLE is committed to achieving certification and recognition from relevant healthcare regulatory bodies.
As of February 2023, MEDIVABLE has several hundred patients using its remote monitoring platform, and the company plans to continue expanding its reach to help even more patients manage their chronic conditions with greater ease and effectiveness.